XML 21 R10.htm IDEA: XBRL DOCUMENT v3.22.1
Cash, cash equivalents, restricted cash, and available-for-sale marketable securities
3 Months Ended
Mar. 31, 2022
Cash, cash equivalents, restricted cash, and available-for-sale marketable securities  
Cash, cash equivalents, restricted cash, and available-for-sale marketable securities

4. Cash, cash equivalents, restricted cash, and available-for-sale marketable securities

Cash, cash equivalents, and marketable securities included the following at March 31, 2022 and December 31, 2021:

Amortized

Unrealized

Unrealized

Fair

    

Cost

    

Gains

    

Losses

    

Value

(in thousands)

As of March 31, 2022

    

    

    

    

    

    

    

    

Money market funds included in cash and cash equivalents

$

78,350

$

$

$

78,350

Marketable securities - U.S. Treasury notes

35,055

(95)

34,960

Total money market funds and marketable securities

$

113,405

$

$

(95)

$

113,310

As of December 31, 2021

    

    

    

    

    

    

    

    

Money market funds included in cash and cash equivalents

$

100,305

$

100,305

Marketable securities - U.S. Treasury notes

15,117

(11)

 

15,106

Total money market funds and marketable securities

$

115,422

$

$

(11)

$

115,411

All of the Company’s marketable debt securities at March 31, 2022, have a contractual maturity of one year or less.

The following table provides a reconciliation of cash, cash equivalents, and restricted cash within the condensed consolidated balance sheets that sum to the total of the same such amounts shown in the condensed consolidated statements of cash flows:

As of March 31, 

2022

    

2021

(in thousands)

Cash and cash equivalents

$

131,873

$

117,799

Restricted cash included in deposits and other non-current assets

1,779

1,779

Total cash, cash equivalents, and restricted cash

$

133,652

$

119,578